Topic

Pennsylvania

A collection of 499 issues

Myths vs. Facts: Getting Evrysdi (Risdiplam) Covered by UnitedHealthcare in Pennsylvania - Appeals Guide 2025

Answer Box: Getting Evrysdi Covered by UnitedHealthcare in Pennsylvania Eligibility: UnitedHealthcare requires prior authorization for Evrysdi with genetic confirmation of SMA, SMN2 copy documentation (2-4 copies for symptomatic patients), and baseline motor function assessments. No step therapy required, but concurrent use with Spinraza is prohibited. Fastest Path: Submit complete PA
6 min read

How to Get Signifor LAR (Pasireotide) Approved by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Signifor LAR Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Signifor LAR (pasireotide) through OptumRx specialty pharmacy. Key requirements: endocrinologist prescription, documented Cushing's disease diagnosis with failed/contraindicated surgery, or acromegaly with failed first-generation somatostatin analogs. Submit complete clinical documentation including labs (24-hour
6 min read

How to Get Cresemba (Isavuconazole) Covered by UnitedHealthcare in Pennsylvania: Appeals, Alternatives & Success Strategies

Answer Box: Getting Cresemba Covered by UnitedHealthcare in Pennsylvania Cresemba (isavuconazole) requires prior authorization from UnitedHealthcare and is typically Tier 3 with step therapy requirements. Your fastest path: 1) Try required alternatives (usually voriconazole, posaconazole, or fluconazole) first or document contraindications/failures, 2) Submit PA through OptumRx with infectious disease
5 min read

How to Get Tavalisse Covered by UnitedHealthcare in Pennsylvania: Complete PA Guide with Forms and Appeal Scripts

Answer Box: Getting Tavalisse Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization and step therapy for Tavalisse (fostamatinib) in Pennsylvania. You need a hematologist to prescribe it, documented failure of corticosteroids and a TPO receptor agonist, and platelet counts typically below 30,000/μL. Submit via the UHC Provider
4 min read